Insider · CIK 0001713863
Rafael Holdings, Inc.
Files at CYTH (Cyclo Therapeutics, Inc.). First filing -, latest -.
In brief
Rafael Holdings, Inc. files SEC Form 4 as 10% owner at CYTH (Cyclo Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rafael Holdings, Inc. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | CYTH Cyclo Therapeutics, Inc. | CConversion Common Stock | +3,968,254 | $0.63 | $2.5M | 12,998,194 | Jan 13, 2025 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | XIn-the-money exercise Common Stock | +2,514,970 | $0.71 | $1.8M | 9,029,940 | Oct 23, 2023 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | XIn-the-money exercise Warrant to Purchase Common Stockderivative | -2,514,970 | $0.13 | $314k | 0 | Oct 23, 2023 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +2,766,467 | - | - | 2,766,467 | Oct 23, 2023 |
Questions about Rafael Holdings, Inc.
Answered from the filings on this page, as of the latest one.
Is Rafael Holdings, Inc. buying or selling?
Rafael Holdings, Inc. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rafael Holdings, Inc.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rafael Holdings, Inc. has 0.
Where does Rafael Holdings, Inc. file Form 4?
Rafael Holdings, Inc. has filed Form 4 at CYTH (Cyclo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.